2013
$38M
from 12 investors over 12 rounds
CRISPR Therapeutics raised undisclosed on December 14, 2020
Investors: Bill & Melinda Gates Foundation
CRISPR Therapeutics raised $38M on June 24, 2016
Investors: New Leaf Venture Partners
CRISPR Therapeutics raised $29M on April 30, 2015
Investors: S.R. One Ltd, Vertex Pharmaceuticals, Celgene, Abingworth and Versant Ventures
CRISPR Therapeutics raised $35M on April 29, 2015
Investors: Versant Ventures, Celgene, Abingworth and S.R. One Ltd
CRISPR Therapeutics raised $25M on April 24, 2014
Investors: Versant Ventures